<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01195064</url>
  </required_header>
  <id_info>
    <org_study_id>RCB 2009-A00916-51, CHU 0921</org_study_id>
    <nct_id>NCT01195064</nct_id>
  </id_info>
  <brief_title>Endothelial Function Study Before Cardiovascular Surgery</brief_title>
  <acronym>COPD-OSAS</acronym>
  <official_title>Endothelial Function Study Before Cardiovascular Surgery in COPD and/or SAS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to evaluate the effect of chronic obstructive pulmonary
      disease (COPD) and/or obstructive sleep apnea syndrome (OSAS) on the endothelial function,
      before cardiovascular surgery, compared to non COPD non OSAS patients undergoing also a
      cardiovascular surgery, by an observational physiological study.

      An interim analysis will be performed when 100 patients will be included.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives of this clinical trial :

        -  To evaluate the effect of COPD and/or OSAS on the systemic inflammation,
           insulin-resistance and oxydative stress, in comparison with non COPD non OSAS patients.

        -  To evaluate the effect of COPD and/or OSAS on the inflammation and oxydative stress of
           the adipose tissue, in comparison with non COPD non OSAS patients.

        -  To validate the STOP-BANG questionnaire in patients undergoing a cardiovascular surgery
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint is the percent of peripheral arterial tone (PAT) in COPD and/or OSAS patients compared to non COPD non OSAS patients.</measure>
    <time_frame>one week before their cardiovascular surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the systemic inflammation, insulin-resistance and oxidative stress occurring during COPD and/or OSAS patients compared to non COPD non OSAS patients.</measure>
    <time_frame>one week before their cardiovascular surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of adipose tissue inflammation and oxidative stress occurring during COPD and/or OSAS patients compared to non COPD non OSAS patients.</measure>
    <time_frame>one week before their cardiovascular surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polysomnography</measure>
    <time_frame>one week before their cardiovascular surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional respiratory exploration</measure>
    <time_frame>one week before their cardiovascular surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <condition>Obstructive Sleep Apnea Syndrome (OSAS)</condition>
  <arm_group>
    <arm_group_label>COPD+ OSAS- patients</arm_group_label>
    <description>Patients with chronic obstructive pulmonary disease (COPD) and without obstructive sleep apnea syndrome (OSAS), before planned cardiovascular surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD- OSAS+ patients</arm_group_label>
    <description>Patients with obstructive sleep apnea syndrome (OSAS) and without chronic obstructive pulmonary disease (COPD), before planned cardiovascular surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD+ OSAS+ patients</arm_group_label>
    <description>Patients with chronic obstructive pulmonary disease (COPD) and with obstructive sleep apnea syndrome (OSAS), with planned cardiovascular surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD- OSAS- patients</arm_group_label>
    <description>Patients without chronic obstructive pulmonary disease (COPD) and without obstructive sleep apnea syndrome (OSAS), before planned cardiovascular surgery</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urinary, blood and adipose tissue samples will be collected for measurement of different
      parameters of inflammation and oxidative stress.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with chronic obstructive pulmonary disease (COPD) and/or obstructive
        sleep apnea syndrome (OSAS) or control patients without these pathologies, before planned
        cardiovascular surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women between 18 and 80 years old

          -  Patient with planned coronary artery bypass graft surgery

          -  Patient with planned peripheral vascular surgery

          -  Patient with aortic surgery

        Exclusion Criteria:

          -  Patient with aortic or mitral valvular replacement

          -  Patient with emergency peripheral valvular surgery

          -  Patient with emergency coronary artery bypass graft surgery

          -  Patient with evolutive malignancy disease

          -  Pregnant or lactating women

          -  Patient with inadvisable bronchodilator (used for functional respiratory) exploration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Louis PEPIN, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Grenoble, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Louis Pépin, MD, PhD</last_name>
    <phone>33-476-765-516</phone>
    <email>JPepin@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric GAGNADOUX, MD, PhD</last_name>
      <phone>33 241 353 695</phone>
      <email>FrGagnadoux@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric GAGNADOUX, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georges LEFTHERIOTIS, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascaline PRIOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wojciech TRZEPIZUR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mutualist Hospital group</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amar DEELCHAND, MD</last_name>
      <phone>33476707057</phone>
      <email>a.deelchand@ghm-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>amar DEELCHAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Yves MEAULLES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis PEPIN, MD, PhD</last_name>
      <phone>33-476-765-516</phone>
      <email>JPepin@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Louis PEPIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick LEVY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine LAUNOIS-ROLLINAT, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud TAMISIER, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal INCAGNOLI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre ALBALADEJO, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guy BARJHOUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Damien BEDAGUE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno CHICHIGNOUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel DURAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel PROTAR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine RHEM, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent BACH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique BLIN, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier CHAVANON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachid HACINI, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Luc MAGNE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmine SESSA, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrice FAURE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Charles RENVERSEZ, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007 Sep 1;370(9589):797-9.</citation>
    <PMID>17765529</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2010</study_first_submitted>
  <study_first_submitted_qc>September 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2010</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD patients</keyword>
  <keyword>OSAS patients</keyword>
  <keyword>cardiovascular surgery</keyword>
  <keyword>Endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

